Back

Triple therapy: still an option?

31 August 2020 (12:22 - 12:33)
Organised by:
Congress Presentation Part of: Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Kurt Huber

Sigmund Freud University Vienna, Vienna (Austria)

3 More presentations in this session

Presentation thumbnail
A historical perspective: why we opted triple therapy for so long and what made us change our mind.
Professor D. Angiolillo (Jacksonville, US)
Slides Video
Presentation thumbnail
Dual versus triple antithrombotic therapy, does trial design make the difference?
Professor R. Storey (Sheffield, GB)
Slides Video
Presentation thumbnail
Dual versus triple antithrombotic therapy - The fine art of personalised medicine.
Professor R. De Caterina (Pisa, IT)
Slides Video

Access the full session

Session thumbnail
Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting

The Event

Event poster

ESC Congress 2020

31 August 2020 12:22 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources